ECONOPRED Drug Patent Profile
✉ Email this page to a colleague
When do Econopred patents expire, and what generic alternatives are available?
Econopred is a drug marketed by Harrow Eye and is included in one NDA.
The generic ingredient in ECONOPRED is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
Summary for ECONOPRED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Clinical Trials: | 3 |
Patent Applications: | 3,813 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ECONOPRED at DailyMed |
Recent Clinical Trials for ECONOPRED
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | Phase 4 |
Winston Chamberlain, MD, PhD | Phase 4 |
Stanford University | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ECONOPRED
US Patents and Regulatory Information for ECONOPRED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | ECONOPRED | prednisolone acetate | SUSPENSION/DROPS;OPHTHALMIC | 017468-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |